Vimarsana
Biggest News Aggregation in the World

Page 8 - Neurological Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurological Sciences Today - Breaking & Trending Today

78% of Nigerians with mental disorder miss treatment —Gureje - Vimarsana News

78% of Nigerians with mental disorder miss treatment —Gureje

A world expert on mental health, Professor Oye Gureje says that in the last 12 months, over 79 percent of Nigerians with current mental health conditions

'She would be dead': UNMC doctor rescues sick mother from Ukraine - Vimarsana News

'She would be dead': UNMC doctor rescues sick mother from Ukraine

KETV first introduced you to Dr. Valentina Gumenyuk back in February, when the UNMC researcher was desperately trying to get her mother to the U.S. from Ukraine. Her mom was diagnosed with a brain tumor and they couldn't wait. Now she says it was thanks to our report, that they're both stateside.

Source: ketv.com
10,048 Nigerians suffering from Multiple Sclerosis - Neurologist - Vimarsana News

10,048 Nigerians suffering from Multiple Sclerosis - Neurologist

About 10,048 Nigerians are suffering from Multiple Sclerosis (MS), a combined brain and spinal cord ailment, the Nigerian Society of Neurological Sciences

icometrix awarded a grant by The Michael J. Fox Foundation to research brain MRI biomarkers for Parkinson's disease - Vimarsana News

icometrix awarded a grant by The Michael J. Fox Foundation to research brain MRI biomarkers for Parkinson's disease

/PRNewswire/ -- icometrix, world leader in imaging artificial intelligence (AI) solutions for people with neurological conditions, has been awarded a grant...

TG Therapeutics Announces Data from the ULTIMATE I and II Phase 3 Trials of BRIUMVI in Multiple Sclerosis to be Presented at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting - Vimarsana News

TG Therapeutics Announces Data from the ULTIMATE I and II Phase 3 Trials of BRIUMVI in Multiple Sclerosis to be Presented at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting

NEW YORK - TG Therapeutics, Inc. , today announced the details of an upcoming oral presentation, highlighting data from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI in patients with... | June 1, 2023